SEC Form 4 · accession 0001140361-16-082999
Aeon Global Health Corp. · AGHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
LAZARUS INVESTMENT PARTNERS LLLP
10% Owner
Justin B Borus
10% Owner
Lazarus Management Co LLC
10% Owner
Lazarus Macro Micro Partners LLLP
10% Owner
Period of report
Oct 14, 2016
Accepted (ET)
Oct 18, 2016 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Oct 14, 2016 | S | 320,000 | $3.25 | D | 423,105 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of common stock were sold directly by Lazarus Investment Partners LLLP ("Lazarus Partners").
- F2This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Partners and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Lazarus Partners, the "Funds"). The securities reported herein are owned directly by Lazarus Partners except for 833 shares of common stock owned directly by Macro Micro Partners. Lazarus Management is the investment adviser and general partner of Lazarus Partners and Mr. Borus is the manager of Lazarus Management.
- F3Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.